(Reuters) - Amicus Therapeutics Inc said its experimental drug significantly reduced the abnormal accumulation of fat in body cells related to a rare genetic disorder that could lead to heart attack, stroke and kidney failure.
via Reuters: Health News Read More Here..
No comments:
Post a Comment